Napp Pharmaceutical

Napp Pharmaceutical is a long-established, private UK pharmaceutical company and a member of the Mundipharma network, specializing in the commercialization of small molecule medicines for the NHS. With a century-long history, it has built a reputation for delivering innovative products while adhering to strong ethical principles, particularly highlighted in its responsible marketing and opioid safety commitments. The company operates in a commercial stage, generating revenue through its portfolio of medicines, and its strategy is deeply intertwined with supporting the NHS's goals, including sustainability and net-zero initiatives.

Commercialization platform focused on the UK NHS; part of the Mundipharma network for product licensing.

Competes with large multinational pharma companies and generic manufacturers for NHS contracts. Differentiation is based on quality, ethical engagement, and a partnership approach to supporting the NHS system, rather than solely on price.